A recent study has shown that the Covid mRNA vaccinations act to reprogram both the adaptive and innate immune systems. What this means is explained below, but the take home message is that immune system dysfunction is produced, which may produce adverse reactions and a resurgence of viral infections, that once healthy immune systems dealt with, including chronic inflammation and autoimmune responses. Thus, the vaccines leave the vaccinated potentially open to further attack by fungi, viruses and bacteria.
“A brand new medRxiv pre-print study entitled: “The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune responses” has graced our world. This paper is so important and it provides evidence to support what many prominent immunologists and vaccinologists have been saying for a long time, including myself. These COVID-19 mRNA injectable products are causing, yes, causing, immune system dysregulation - and not just in the context of the adaptive system, but in the context of the innate system. Not only that, but these findings provide very good reasons as to why we are seeing resurgences of latent viral infections and other adverse events reported in VAERS (and other adverse event reporting systems) and perhaps more importantly, why we should under no circumstances inject this crap into our children. Children are fine in the context of COVID-19 (for the 80 millionth time - this well documented) and this is due to their extraordinary innate immune response systems.
In a nutshell, in this article, what they found was that the BNT162b2 (Pfizer/BioNTech) injectable products are modulating the production of inflammatory cytokines by innate immune cells upon stimulation with both specific (SARS-CoV-2) and non-specific (viral, fungal and bacterial) stimuli whereby the response of innate immune cells to TLR4 and TLR7/8 ligands was weaker after BNT162b2 injection, while fungi-induced cytokine responses were stronger.
In conclusion, the mRNA BNT162b2 vaccine induces complex functional reprogramming of innate immune responses, which should be considered in the development and use of this new class of vaccines.
Yes. It should be. And it should have been.”
https://www.medrxiv.org/content/10.1101/2021.05.03.21256520v1